Terminated PHASE2 INTERVENTIONAL 1-arm NCT02154087

A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (MOA 034)

Sponsor: Healthpoint

Interventions HP802-247

Updated 6 times since 2017 Last updated: Sep 19, 2016 Started: Jul 31, 2014 Primary completion: Jul 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

based on outcome of previous study

Other terminated trials from Healthpoint

See all terminations from Healthpoint

This PHASE2 trial investigates Venous Leg Ulcers and is currently terminated or withdrawn. Healthpoint leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Healthpoint

Data source: Healthpoint

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Columbus, United States